Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2016-12-12 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VOIRON (38500), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE GERBAKA : revenue, balance sheet and financial ratios
SELAS PHARMACIE GERBAKA is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VOIRON (38500),
this company of category PME
shows in 2025 a net income positive of 200 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE GERBAKA (SIREN 823904040)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
199 714 €
179 671 €
137 059 €
243 101 €
176 108 €
127 602 €
-17 155 €
1 551 €
-37 448 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE GERBAKA generates positive net income of 200 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
199 714 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 142%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
141.795%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.823%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
133.163
1098.855
11042.645
556.265
214.501
113.631
64.927
39.03
141.795
Financial autonomy
5.662
5.004
0.667
11.095
22.869
33.101
41.68
47.48
25.823
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
141.792025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+26 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE GERBAKA (141.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.82%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-16 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE GERBAKA (25.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 209.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
190.267
97.899
165.291
202.699
227.331
243.949
238.401
232.701
208.996
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
209.02025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-6 pts over 3 years
In 2025, the liquidity ratio of SELAS PHARMACIE GERBAKA (209.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE GERBAKA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE GERBAKA is estimated at
3 172 480 €
(range 2 152 860€ - 4 978 058€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2152k€3172k€4978k€
3 172 480 €Range: 2 152 860€ - 4 978 058€
NAF 5 année 2025
Valuation method used
Net Income Multiple
199 714 €
×
15.9x
=3 172 481 €
Range: 2 152 860€ - 4 978 059€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE GERBAKA with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE GERBAKA
What is the revenue of SELAS PHARMACIE GERBAKA ?
The revenue of SELAS PHARMACIE GERBAKA is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE GERBAKA profitable?
Yes, SELAS PHARMACIE GERBAKA generated a net profit of 200 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE GERBAKA ?
The headquarters of SELAS PHARMACIE GERBAKA is located in VOIRON (38500), in the department Isere.
Where to find the tax return of SELAS PHARMACIE GERBAKA ?
The tax return of SELAS PHARMACIE GERBAKA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE GERBAKA operate?
SELAS PHARMACIE GERBAKA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart